综述 |
|
|
|
|
工程化P450酶特异性氧化修饰甾体化合物 * |
常庆娜1,2,3,姚明东1,2,3,**( ),王颖1,2,肖文海1,2,元英进1,2 |
1 天津大学系统生物工程教育部重点实验室 天津 300072 2 天津大学天津化学化工协同创新中心合成生物学平台 天津 300072 3 天津大学前沿技术研究院 天津 301700 |
|
Engineering P450 for Specific Oxidation of Steroids |
CHANG Qing-na1,2,3,YAO Ming-dong1,2,3,**( ),WANG Ying1,2,XIAO Wen-hai1,2,YUAN Ying-jin1,2 |
1 Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300072, China 2 SynBio Research Platform, Collaborative Innovation Center of Chemical Science and Engineering, Tianjin University, Tianjin 300072, China |
引用本文:
常庆娜,姚明东,王颖,肖文海,元英进. 工程化P450酶特异性氧化修饰甾体化合物 *[J]. 中国生物工程杂志, 2018, 38(12): 99-112.
CHANG Qing-na,YAO Ming-dong,WANG Ying,XIAO Wen-hai,YUAN Ying-jin. Engineering P450 for Specific Oxidation of Steroids. China Biotechnology, 2018, 38(12): 99-112.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20181213
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I12/99
|
[1] |
曹飞飞, 范永仙, 陈小龙 . 细胞色素P450酶系介导的甾体羟化反应及其在分子水平上的研究进展. 国外医药(抗生素分册), 2013,34(4):149-152.
|
|
Cao F F, Fan Y X, Chen X L . Cytochrome P450 systerms mediated hydroxylation in steroids and the development of P450 systerms gene. World Notes on Antibiotics, 2013,34(4):149-152.
|
[2] |
胡海峰, 李晓敦, 朱宝泉 . 微生物甾体羟化技术及其应用. 国外医药(抗生素分册), 2006,27(2):76-78.
|
|
Hu H F, Li X D, Zhu B Q . The steroid hydroxylation technology of microbial and its application. World Notes on Antibiotics, 2006,27(2):76-78.
|
[3] |
Egorova O V, Gulevskaya S A, Puntus I F , et al. Production of androstenedione using mutants of Mycobacterium sp. Journal of Chemical Technology & Biotechnology, 2002,77(2):141-147.
|
[4] |
Wrońska N, Brzostek A, Szewczyk R , et al. The role of fadD19 and echA19 in sterol side chain degradation by Mycobacterium smegmatis. Molecules, 2016,21(5):598.
|
[5] |
叶丽, 周珮 . 微生物甾体羟化酶及羟化反应机理研究//全国生化与生物技术药物学术年会. 吉林: 中国药学会, 2008: 262-265.
|
|
Ye L, Zhou P . Researching on mechanism of microbial steroid hydroxylase and hydroxylation//National Academic Conference on Biochemical and Biotechnological Drugs. Jilin: Chinese Pharmaceutical Association, 2008: 262-265.
|
[6] |
Vanegas K G, Larsen A B, Eichenberger M , et al. Indirect and direct routes to C-glycosylated flavones in Saccharomyces cerevisiae. Microbial Cell Factories, 2018,17(1):107.
|
[7] |
王鸿, 周峰, 吴祺豪 , 等, 甾体类化合物生物转化的研究进展. 浙江工业大学学报, 2015,43(5):556-561.
|
|
Wang H, Zhou F, Wu Q H , et al. Recent advances in steroid biotransformation. Journal of Zhejiang Uinversity of Technology, 2015,43(5):556-561.
|
[8] |
Petri c ˙ ? , Hakki T, Bernhardt R , et al. Discovery of a steroid 11α-hydroxylase from Rhizopus oryzae and its biotechnological application. Journal of Biotechnology, 2010,150(3):428-437.
|
[9] |
Abdulmughni A, Józwik I K, Putkaradze N , et al. Characterization of cytochrome P450 CYP109E1 from Bacillus megaterium as a novel vitamin D3 hydroxylase. Journal of Biotechnology, 2017,243:38-47.
doi: 10.1016/j.jbiotec.2016.12.023
|
[10] |
柯霞, 孙骏, 郑裕国 . P450酶系中高效电子传递链的构建及应用. 生命的化学, 2015,35(6):733-740.
|
|
Ke X, Sun J, Zheng Y G . Construction and application of the high efficient electron transfer chain for cytochrome P450. Chemistry of Life, 2015,35(6):733-740.
|
[11] |
Li S, Li Y, Smolke C D . Strategies for microbial synthesis of high-value phytochemicals. Nature Chemistry, 2018,10(4):395-404.
doi: 10.1038/s41557-018-0013-z
pmid: 29568052
|
[12] |
Nikolaus J, Nguyen K T, Virus C , et al. Engineering of CYP106A2 for steroid 9α- and 6β-hydroxylation. Steroids, 2017,120:41-48.
doi: 10.1016/j.steroids.2017.01.005
|
[13] |
Ehrhardt M, Gerber A, Hannemann F , et al. Expression of human CYP27A1 in B. megaterium for the efficient hydroxylation of cholesterol, vitamin D3 and 7-dehydrocholesterol. Journal of Biotechnology, 2016,218:34-40.
doi: 10.1016/j.jbiotec.2015.11.021
pmid: 26638999
|
[14] |
Hausjell J, Halbwirth H , Spadiut O. Recombinant production of eukaryotic cytochrome P450s in microbial cell factories.Bioscience Reports, 2018, 38(2): BSR20171290.
doi: 10.1042/BSR20171290
pmid: 29436484
|
[15] |
Zelasko S, Palaria A, Das A . Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems. Protein Expression and Purification, 2013,92(1):77-87.
doi: 10.1016/j.pep.2013.07.017
pmid: 23973802
|
[16] |
Omura T, Gotoh O . Evolutionary origin of mitochondrial cytochrome P450. The Journal of Biochemistry, 2017,161(5):399-407.
doi: 10.1093/jb/mvx011
pmid: 28338801
|
[17] |
Omura T . Structural diversity of cytochrome P450 enzyme system. The Journal of Biochemistry, 2010,147(3):297-306.
doi: 10.1093/jb/mvq001
pmid: 20068028
|
[18] |
Bakkes P J, Biemann S, Bokel A , et al. Design and improvement of artificial redox modules by molecular fusion of flavodoxin and flavodoxin reductase from Escherichia coli. Scientific Reports, 2015,5:12158.
doi: 10.1038/srep12158
pmid: 4503991
|
[19] |
Hannemann F, Virus C, Bernhardt R . Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. Journal of Biotechnology, 2006,124(1):172-181.
doi: 10.1016/j.jbiotec.2006.01.009
pmid: 16504331
|
[20] |
Bracco P, Janssen D B, Schallmey A , et al. Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450. Microbial Cell Factories, 2013,12(1):95.
doi: 10.1186/1475-2859-12-95
pmid: 24134652
|
[21] |
Sawada N, Sakaki T, Yoneda S , et al. Conversion of vitamin D3 to 1α,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1. Biochemical and Biophysical Research Communications, 2004,320(1):156-164.
doi: 10.1016/j.bbrc.2004.05.140
pmid: 15207715
|
[22] |
Schiffler B, Bureik M, Reinle W , et al. The adrenodoxin-like ferredoxin of Schizosaccharomyces pombe mitochondria. Journal of Inorganic Biochemistry, 2004,98(7):1229-1237.
|
[23] |
Bakkes P J, Riehm J L, Sagadin T , et al. Engineering of versatile redox partner fusions that support monooxygenase activity of functionally diverse cytochrome P450s. Scientific Reports, 2017,7(1):9570.
doi: 10.1038/s41598-017-10075-w
pmid: 28852040
|
[24] |
Litzenburger M, Bernhardt R . CYP260B1 acts as 9α-hydroxylase for 11-deoxycorticosterone. Steroids, 2017,127:40-45.
doi: 10.1016/j.steroids.2017.08.006
pmid: 28827071
|
[25] |
Neunzig I, Widjaja M, Peters F T , et al. Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe. Applied Biochemistry and Biotechnology, 2013,170(7):1751-1766.
doi: 10.1007/s12010-013-0303-2
pmid: 23737303
|
[26] |
Chang J J, Thia C, Lin H Y , et al. Integrating an algal β-carotene hydroxylase gene into a designed carotenoid-biosynthesis pathway increases carotenoid production in yeast. Bioresource Technology, 2015,184:2-8.
doi: 10.1016/j.biortech.2014.11.097
pmid: 25537137
|
[27] |
Ding M Z, Yan H F, Li L F , et al. Biosynthesis of taxadiene in Saccharomyces cerevisiae: selection of geranylgeranyl diphosphate synthase directed by a computer-aided docking strategy. PLoS One, 2014,9(10):e109348.
doi: 10.1371/journal.pone.0109348
pmid: 25295588
|
[28] |
Sarria S, Wong B, Martín H G , et al. Microbial synthesis of pinene. ACS Synthetic Biology, 2013,3(7):466-475.
|
[29] |
Xie W, Lv X, Ye L , et al. Construction of lycopene-overproducing Saccharomyces cerevisiae by combining directed evolution and metabolic engineering. Metabolic Engineering, 2015,30:69-78.
doi: 10.1016/j.ymben.2015.04.009
pmid: 25959020
|
[30] |
Omura T, Gotoh O . Evolutionary origin of mitochondrial cytochrome P450. The Journal of Biochemistry, 2017,161(5):399-407.
doi: 10.1093/jb/mvx011
pmid: 28338801
|
[31] |
Sakaki T, Kominami S, Hayashi K , et al. Molecular engineering study on electron transfer from NADPH-P450 reductase to rat mitochondrial P450c27 in yeast microsomes. Journal of Biological Chemistry, 1996,271(42):26209-26213.
doi: 10.1074/jbc.271.42.26209
pmid: 8824269
|
[32] |
Brixius S, Schiffer L, Hannemann F , et al. A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol. Microb Cell Fact, 2015,14(1):135.
doi: 10.1186/s12934-015-0333-2
pmid: 4572648
|
[33] |
Schiffer L, Anderko S, Hobler A , et al. A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale. Microbial Cell Factories, 2015,14(1):1-12.
doi: 10.1186/s12934-015-0209-5
pmid: 4347555
|
[34] |
Vimercati S, Büchi M, Zielinski J , et al. Testosterone metabolism of equine single CYPs of the 3A subfamily compared to the human CYP3A4. Toxicology in Vitro, 2017,41:83-91.
doi: 10.1016/j.tiv.2017.02.017
pmid: 28238727
|
[35] |
Sergeev G V, Gilep A A, Usanov S A . The role of cytochrome b5 structural domains in interaction with cytochromes P450. Biochemistry (Mosc), 2014,79(5):406-416.
doi: 10.1134/S0006297914050046
pmid: 24954591
|
[36] |
Duggal R, Liu Y, Gregory M C , et al. Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis. Biochem Biophys Res Commun, 2016,477(2):202-208.
doi: 10.1016/j.bbrc.2016.06.043
pmid: 4935565
|
[37] |
Duggal R, Denisov I G, Sligar S G . Cytochrome b5 enhances androgen synthesis by rapidly reducing the CYP17A1 oxy-complex in the lyase step. FEBS Lett, 2018,592(13):2282-2288.
doi: 10.1002/1873-3468.13153
|
[38] |
Im S C, Waskell L . The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5). Archives of Biochemistry & Biophysics, 2011,507(1):144-153.
doi: 10.1016/j.abb.2010.10.023
pmid: 21055385
|
[39] |
Zhang H, Yokom A L, Cheng S , et al. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis. The Journal of Biological Chemistry, 2018,293(20):7727-7736.
doi: 10.1074/jbc.RA117.000600
pmid: 29618513
|
[40] |
Ortega U S, Luirink R A, Geerke D P , et al. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium. Journal of Inorganic Biochemistry, 2018,180:47-53.
|
[41] |
Johnson E O D, Wong L . Partial fusion of a cytochrome P450 system by carboxy-terminal attachment of putidaredoxin reductase to P450cam (CYP101A1). Catalysis Science & Technology, 2016,6(20):7549-7560.
doi: 10.1039/C6CY01042C
pmid: 5609660
|
[42] |
Fisher C W, Shet M S, Caudle D L , et al. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. Proceedings of the National Academy of Sciences of the United States of America, 1992,89(22):10817-10821.
doi: 10.1073/pnas.89.22.10817
pmid: 1438282
|
[43] |
Bakkes P J, Riehm J L, Sagadin T , et al. Engineering of versatile redox partner fusions that support monooxygenase activity of functionally diverse cytochrome P450s. Scientific Reports, 2017,7(1):9570.
doi: 10.1038/s41598-017-10075-w
pmid: 28852040
|
[44] |
Strushkevich N, Mackenzie F, Cherkesova T , et al. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proceedings of the National Academy of Sciences of the United States of America, 2011,108(25):10139-10143.
doi: 10.1073/pnas.1019441108
pmid: 21636783
|
[45] |
Hirakawa H, Nagamune T . Molecular assembly of P450 with ferredoxin and ferredoxin reductase by fusion to PCNA. ChemBioChem, 2010,11(11):1517-1520.
doi: 10.1002/cbic.201000226
pmid: 20607777
|
[46] |
O’Reilly E, K?hler V, Flitsch S L , et al. Cytochromes P450 as useful biocatalysts: addressing the limitations. Chemical Communications, 2011,47(9):2490-2501.
doi: 10.1039/c0cc03165h
pmid: 21264369
|
[47] |
Meunier B, de Visser S P, Shaik S . Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chemical Reviews, 2004,104(9):3947-3980.
doi: 10.1021/cr020443g
pmid: 15352783
|
[48] |
van Vugt-Lussenburg B M A, Stjernschantz E, Lastdrager J , et al. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. Journal of Medicinal Chemistry, 2007,50(3):455-461.
doi: 10.1021/jm0609061
pmid: 17266197
|
[49] |
Cha G S, Ryu S H, Ahn T , et al. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium. Biotechnology Letters, 2014,36(12):2501-2506.
doi: 10.1007/s10529-014-1628-9
|
[50] |
Khatri Y, Józwik I K, Ringle M , et al. Structure-based engineering of steroidogenic CYP260A1 for stereo- and regioselective hydroxylation of progesterone. ACS Chemical Biology, 2018,13(4):1021-1028.
doi: 10.1021/acschembio.8b00026
pmid: 29509407
|
[51] |
Gregory M C, Mak P J, Khatri Y , et al. Human P450 CYP17A1: control of substrate preference by asparagine 202. Biochemistry, 2018,57(5):764-771.
doi: 10.1021/acs.biochem.7b01067
pmid: 29283561
|
[52] |
Swart A C, Storbeck K, Swart P . A single amino acid residue, Ala 105, confers 16α-hydroxylase activity to human cytochrome P450 17α-hydroxylase/17,20 lyase. The Journal of Steroid Biochemistry and Molecular Biology, 2010,119(3-5):112-120.
doi: 10.1016/j.jsbmb.2009.12.014
pmid: 20043997
|
[53] |
陈勇, 王淑珍, 陈依军 . 酶的理性设计. 药物生物技术, 2011,18(6):538-543.
|
|
Chen Y, Wang S Z, Chen Y J . Rational design of enzymes. Pharmaceutical Biotechnology, 2011,18(6):538-543.
|
[54] |
Schiavini P, Cheong K J, Moitessier N , et al. Active site crowding of P450 3A4 as a strategy to alter its selectivity. Chembiochem A European Journal of Chemical Biology, 2016,18(3):248-252.
doi: 10.1002/cbic.201600546
pmid: 27897366
|
[55] |
Cirino P C, Arnold F H . A self-sufficient peroxide-driven hydroxylation biocatalyst. Angewandte Chemie, 2003,42(28):3299-3301.
doi: 10.1002/ange.200351434
pmid: 12876749
|
[56] |
Li Q, Ogawa J, Shimizu S . Critical role of the residue size at position 87 in H2O2-dependent substrate hydroxylation activity and H2O2 inactivation of cytochrome P450BM-3. Biochemical and Biophysical Research Communications, 2001,280(5):1258-1261.
doi: 10.1006/bbrc.2001.4261
pmid: 11162663
|
[57] |
Jensen K, Jensen P E, M?ller B L . Light-driven cytochrome p450 hydroxylations. Acs Chemical Biology, 2011,6(6):533-539.
doi: 10.1021/cb100393j
pmid: 21323388
|
[58] |
Shalan H, Kato M, Cheruzel L . Keeping the spotlight on cytochrome P450.Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2017,1866(1):80-87.
doi: 10.1016/j.bbapap.2017.06.002
pmid: 28599858
|
[59] |
Zehentgruber D, Dr?gan C A, Bureik M , et al. Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe. Journal of Biotechnology, 2010,146(4):179-185.
doi: 10.1016/j.jbiotec.2010.01.019
pmid: 20132843
|
[60] |
Zehentgruber D, Bernhardt R, Bleif R , et al. Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. ChemBioChem, 2010,11(5):713-721.
doi: 10.1002/cbic.200900706
pmid: 20183841
|
[61] |
Schwaneberg U . Entwicklung eines in vitro cytochrome P450 CYP102 (BM-3) enzym-membran-reaktors//Klonierung, fermentation, reinigung und assayentwicklug zur charakterisierung und gerichteten evolution der monooxygenase P450 BM-3 aus Bacillus megaterium. Germany: GCA, 1999: 84-85.
|
[62] |
Szczebara F M, Chandelier C, Villeret C , et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nature Biotechnology, 2003,21(2):143-149.
doi: 10.1038/nbt775
pmid: 12514739
|
[63] |
Ott R G, Athenstaedt K, Hrastnik C , et al. Flux of sterol intermediates in a yeast strain deleted of the lanosterol C-14 demethylase Erg11p. BBA - Molecular and Cell Biology of Lipids, 2005,1735(2):111-118.
|
[64] |
Hammer S K, Avalos J L . Harnessing yeast organelles for metabolic engineering. Nature Chemical Biology, 2017,13(8):823-832.
doi: 10.1038/nchembio.2429
pmid: 28853733
|
[65] |
梅兴国, 黄伟 . 红豆杉细胞两相培养生产紫杉醇的研究. 生物技术, 2000,10(1):10-12.
|
|
Mei X G, Huang W . Production of taxol by two-phase culture Taxus cell suspension. Biotechnology, 2000,10(1):10-12.
|
[66] |
龙泉鑫, 周培富, 吴宗辉 , 等. 微生物药物外排泵及其抑制剂研究. 药学学报, 2008,43(11):1082-1088.
|
|
Long Q X, Zhou P F, Wu Z H , et al. Advances in the study of the microbialefflux pumps and its inhibitors development. Acta Pharmaceutica Sinica, 2008,43(11):1082-1088.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|